
In SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.
Children diagnosed with autism spectrum disorder are 9 times more likely to present to the emergency department (ED) for psychiatric reasons.






